Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Bevacizumab plus ipilimumab in patients with metastatic melanoma.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Bevacizumab plus ipilimumab in patients with metastatic melanoma.
Bevacizumab plus ipilimumab in patients with metastatic melanoma. Cancer Immunol Res. 2014 Jul; 2(7):632-42.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Neoplasm
Antineoplastic Combined Chemotherapy Protocols
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Lymphocytes, Tumor-Infiltrating
Male
Melanoma
Middle Aged
Neoplasm Staging
Neovascularization, Pathologic
Treatment Outcome
authors with profiles
Elsa F Velazquez, M.D.
Martin Charles Mihm Jr., M.D.
David Francis McDermott, M.D.
Scott J. Rodig, Ph.D., M.D.
Keith Thomas Flaherty, M.D.
George Francis Murphy, M.D.
Annick Diane Van Den Abbeele, M.D.
Pamela DiPiro, M.D.
Frank Stephen Hodi, M.D.